Q: I am down more than 30% on CRH on a small position. Is it still wort keeping or time to move on to better stocks..
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Would IBB be best in a TFSA or non-registered
Q: Hi Folks
Is there a Canadian dollar way to play the Biotech industry. Would it be correct to say that IBB would be a US dollar purchase?
Thanks for all you do
GUY R
Is there a Canadian dollar way to play the Biotech industry. Would it be correct to say that IBB would be a US dollar purchase?
Thanks for all you do
GUY R
Q: Your April 27, 2017 response says GUD's patience does not mean anything is wrong. Goodman is currently away in Israel for discussion with Medison
Biotech. Hope GUD goes commercial in 2017. Any comment on this move ?
Biotech. Hope GUD goes commercial in 2017. Any comment on this move ?
Q: Hi All at 5i!!! I know that you don't follow Us stocks BUT...if you had to choose one of the following for a long term hold, which would it be ? Cheers, Tamara...PS. I really hope you will create a Us stock portfolio....just saying....😁😁😁
Q: GUD. Should my entry point of 10.15 be breached, should I remain in, and hope for the best ?
Q: Can you please comment on Savaria's earnings? Thank you
Q: It appears the $1.65/share takeover by Norgine is set for Sept 30, 2017. Between now an then do you see any other upside above $1.65? I read at Pharmpro.com, 'The Arrangement Agreement includes a non-solicitation covenant on the part of Merus, subject to customary "fiduciary out" provisions that entitle Merus to consider and accept unsolicited superior proposals and a right in favour of Norgine to match any superior proposal....'
Q: Hi 5i - can I get your comments on CXR's results? Anything to like here? Thanks, Neil
Q: Although this is probably too early for an opinion about the suggested suit again Span-America, what are you experiences in other similar situations?
Thanks.
Thanks.
Q: Do you know approximately what percentage of Savaria's top line revenue comes from its servicing of the equipment that it has sold?
Q: What do you think is the potential impact of the following? Thanks.
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Span-America Medical Systems, Inc. And Encourages Investors To Contact The Firm For Additional Information
Details: http://www.businesswire.com/news/home/20170510006321/en/SHAREHOLDER-ALERT-Brower-Piven-Commences-Investigation-Proposed
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Span-America Medical Systems, Inc. And Encourages Investors To Contact The Firm For Additional Information
Details: http://www.businesswire.com/news/home/20170510006321/en/SHAREHOLDER-ALERT-Brower-Piven-Commences-Investigation-Proposed
Q: Dropping presently due to new purchase. Is this a buying opportunity of concern?
Q: What's your updated view on this name?
Q: Thoughts on recent earnings? Is this a lost cause?
Q: I have a sizeable position in the stock and am down 20%. Debating whether I should hold or sell. It's in a taxable account so could utilize the loss for tax purposes. Don't see a catalyst in the near future and the board and management don't seem to be in a rush to create one. Thx
Q: Is it time to revisit this beat up stock? Seems to be generating decent cash from operations and is cheap as borscht.
Thank for your sage advice as usual.
Thank for your sage advice as usual.
Q: Peter and Team:
PHM has hit a 52 week high. Last question about it was asked April 28. Wondering if your thoughts are still negative, and if you could expand on the proposed split.
Thanks as always for a great service.
Phil
PHM has hit a 52 week high. Last question about it was asked April 28. Wondering if your thoughts are still negative, and if you could expand on the proposed split.
Thanks as always for a great service.
Phil
Q: Today is GUD' s annual meeting and owning some stock means i can attend. But is it worth the traffic and time or just the online documents be just as good ?
There aren't to many in this area that i can attend except WSP tomorrow and SIS next monday.
Would it be a learning experience?
There aren't to many in this area that i can attend except WSP tomorrow and SIS next monday.
Would it be a learning experience?
-
Gold Springs Resource Corp. (GRC $0.08)
-
Merus Labs International Inc. (MSL $1.65)
-
Cipher Pharmaceuticals Inc. (CPH $14.70)
Q: All three of these companies were once market darlings that have fallen from their more favorable market days and are now attempting turnarounds. Do any of these companies appear to be a turnaround buy at their current levels? If not,and if they sit in one's portfolio, should they be ejected? if so, how would they rate from worst (eject 1st)to best (still hope, eject last).
Thanks!
Thanks!